Avience Biomedicals Ltd IPO

Experienced Management Team and trained Employees.

Optimal Utilization of Resources.

Quality assurance and control.

Cordial relationships with our clients.

The pharmaceutical market is subject to extensive regulation and failures to comply with the existing and future regulatoryrequirements in any pharmaceutical market could expose us to litigation or other liabilities, which could adversely affectour reputation, business, financial condition and results of operations.

We are dependent on certain customers for a portion of our revenues. The loss of any of our major customers due to anyadverse development or significant reduction in business from our major customers may adversely affect our business,financial condition, results of operations and future prospects.

We rely on suppliers for medical devices and equipment manufacturers for our trading goods, and also face risks in sourcingraw materials and components from third parties for the manufacturing and assembly of our medical equipment. Anydisruption in the supply of these goods or materials could adversely impact our business, operations, and financial condition.

Our Financial Statement as Restated are prepared and signed by the Peer Review Auditor who is not Statutory Auditors ofour Company as required under the provisions of ICDR.

Our business derives a significant portion of its revenue from the trading sector, and any potential instability in this areacould pose a risk to our overall performance.

The purchase and sale of medical devices and equipment for our trading activities are significantly dependent on relatedparties.

Customer orders may experience delays, modifications, cancellations, or may not be fully paid, which could negativelyimpact our business, financial condition, and operational results.

We require sizeable amounts of working capital for our continued operation and growth. Our inability to meet our workingcapital requirements could have a material adverse effect on our business, results of operations and financial condition.

Our business depends on the efficient functioning of our manufacturing facilities and assembly units. Although we havenot received any product-related complaints, occasional machinery breakdowns in the past highlight the importance ofregular maintenance and operational enhancements. Any unforeseen obsolescence, damage, theft, or delays in repair couldhave an adverse impact on our operations, cash flows, financial condition, and results.

We import a portion of our raw material supply from China. Restrictions on or import duties relating to materials andequipment imported for our manufacturing operations as well as restrictions on or import duties levied on our products inour export markets may adversely affect our business prospects, financial performance and cash flows.